Finizio Robert G 4
4 · ZyVersa Therapeutics, Inc. · Filed Dec 14, 2022
Insider Transaction Report
Form 4
Finizio Robert G
Director
Transactions
- Award
Stock Options (right to buy)
2022-12-12+19,854→ 19,854 totalExercise: $16.36Exp: 2031-02-08→ Common Stock (19,854 underlying) - Award
Stock Options (right to buy)
2022-12-12+9,927→ 9,927 totalExercise: $16.36Exp: 2032-01-28→ Common Stock (9,927 underlying) - Award
Stock Options (right to buy)
2022-12-12+29,781→ 29,781 totalExercise: $11.58Exp: 2029-04-02→ Common Stock (29,781 underlying)
Footnotes (3)
- [F1]100% of the option is immediately exercisable. The option vested in 3 equal annual installments commencing on April 2, 2020.
- [F2]The option vests in 3 equal annual installments commencing on February 8, 2022.
- [F3]The option vests in 3 equal annual installments commencing on January 28, 2023.